AzTrials
AzTrials

Emergency Medical ServicesAl-MDSNCT05974163

Development of an AI-based Emergency Imaging Multi-Disease Rapid Joint Screening System

An observational study of Emergency Medical Services and Critical Illness, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Introduction: Early and rapid diagnosis of etiology is often an important part of saving the lives of patients in emergency department. Chest CT is an important examination method for emergency diagnosis because of its fast examination speed and accurate localization. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
What is being tested?
radiomic of CT
How many people
10,000 participants
Where
1 siteChina
Study dates
1 Aug 2023to 31 Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: We plan to recruit 1000 patients in discovering group, 8000 patients in internal validation, and 2000 patients in external validation group. Patients between 18 and 100 years of age with cardiovascular, respiratory, digestive, and neurological disorders. CT imaging was available.

Who may be able to join

  • Adults with cardiovascular, respiratory, digestive, and neurological disorders. CT imaging was available.

Who cannot join

  • Patients with incomplete clinical or radiographic data were excluded.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou

    LI LI, M.D., 02034071029, lil3@mail.sysu.edu.cn

Other trials in China

About this study

Official title: Development of a Multi-Disease Screening System for Emergency CT Imaging Based on Artificial Intelligence

Introduction:

Early and rapid diagnosis of etiology is often an important part of saving the lives of patients in emergency department. Chest CT is an important examination method for emergency diagnosis because of its fast examination speed and accurate localization. Traditional medical imaging diagnosis relies on radiologists to report in a qualitative and subjective manner. Through the interdisciplinary combination of clinical, imaging and artificial intelligence, the integration of multi-omics data, the construction of large-scale language models, and the construction of the auxiliary diagnosis support system of "one check for multiple diseases" provide new ideas and means for the rapid and accurate screening of emergency critical diseases.

Read more

Method:

Study design Investigators retrospectively collected cardiovascular, respiratory, digestive, and neurological CT images, demographic data, medical history and laboratory date of emergency department patients during the period from 1 January 2018 and 30 December 2024. Regularly carry out standardized follow-up work, and complete the collection and database establishment of clinical-imaging multi-omics data of patients attending emergency department.The inclusion criteria are:1. adult emergency patients with cardiovascular, respiratory, digestive, and nervous system diseases; 2. These patients had CT images. Patients with incomplete clinical or radiographic data were excluded from the analysis. Regularly carry out standardized follow-up work, and complete the collection and database establishment of clinical-imaging multi-omics data of patients attending emergency department.

Based on the collected medical text data, an artificial intelligence large-scale language model algorithm framework is built. After the structure annotation of chest CT images is performed by doctors above the intermediate level of imaging, the Transformer deep neural network is trained for CT image segmentation, and a series of tasks such as structural structure segmentation, damage detection, disease classification and automatic report generation are developed based on Vision Transformer self-attention architecture mechanism. A multi-disease diagnosis and treatment decision-making system based on chest CT images, clinical text and examination multimodal data was constructed and validated.

Disscusion

Emergency medicine deals mainly with unpredictable critical and sudden illnesses. Patients who come to the emergency department for medical treatment often have acute onset, hidden condition, rapid progress, many complications, high mortality and disability rate. Assisted diagnosis systems developed by combining clinical text, images and artificial intelligence can greatly improve the ability of emergency department doctors to accurately diagnose diseases. This study fills the blank of CT artificial intelligence aided diagnosis system for emergency patients, and provides a rapid diagnosis scheme for multi-system and multi-disease. Finally, the results will be transformed into clinical application software and used and promoted in clinical work to improve the diagnosis and treatment level.

Being tested
radiomic of CT
Medical subject headings
Critical Illness, Emergencies, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • radiomic of CTDiagnostic test

    Computed Tomography (CT) is often an important examination method for emergency diagnosis because of its fast examination speed and accurate localization acute respiratory distress syndrome.

Study groups in NCT05974163
Study groupRoleWhat they receive
Model reconstruction cohort8000 patients were recruited retrospectively from January 2023 to December 2025 as discovering group.
Receives: Diagnostic Test: radiomic of CT
External Validation cohort 11000 patients were recruited retrospectively from January 2023 to December 2025 as internal validation group.
Receives: Diagnostic Test: radiomic of CT
External validation cohort 21000 patients will be recruited prospectively during the period from January 2023 to December 2025 as external validation group
Receives: Diagnostic Test: radiomic of CT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of disease diagnosis

    Construct a rapid diagnosis, accurate and efficient emergency CT image multi-disease rapid joint screening system

    Measured: 2025-08-01~2025-12-31

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2023
  2. Study start1 Aug 2023 (estimated)
  3. Primary completion31 Jul 2024 (estimated)
  4. Study completion31 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05974163
Sponsor's protocol ID
SYSKY-2023-375-01
Acronym
Al-MDS
Status last verified
Jul 2023
First submitted
26 Jul 2023
Last updated
3 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: individual participant data in this research can contact lil3 @mail.sysu.edu.cn for reasonable requests

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Medical Services and Critical Illness, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact LI LI (02034071029, lil3@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of disease diagnosis (time frame: 2025-08-01~2025-12-31). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in